2023
DOI: 10.1016/j.pmedr.2023.102157
|View full text |Cite
|
Sign up to set email alerts
|

Impact of the COVID-19 pandemic on the breast cancer early diagnosis program in Brazil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…Worldwide, there have been few reports on the impact of the COVID-19 pandemic on cancer screening beyond 2021. In the United States and Brazil, breast, cervical, and prostate cancer screening rates declined significantly in 2020 and did not recover to 2019 levels even in 2021 ( Oakes et al, 2023 , Antonini et al, 2023 ). Another US report found that colorectal cancer screening rates in 2021 exceeded those in 2019 ( Star et al, 2023 ).…”
Section: Discussionmentioning
confidence: 99%
“…Worldwide, there have been few reports on the impact of the COVID-19 pandemic on cancer screening beyond 2021. In the United States and Brazil, breast, cervical, and prostate cancer screening rates declined significantly in 2020 and did not recover to 2019 levels even in 2021 ( Oakes et al, 2023 , Antonini et al, 2023 ). Another US report found that colorectal cancer screening rates in 2021 exceeded those in 2019 ( Star et al, 2023 ).…”
Section: Discussionmentioning
confidence: 99%
“… 2 Other reports have corroborated these data. 3 , 4 After the restrictive measures of the pandemic were eased and vaccination implemented, the consequent contraction in SARS-CoV-2 infection rates and COVID-19–related mortality proved insufficient to restore breast cancer screening coverage to pre-COVID levels. 2 , 3 Indeed, in 2021, an increase was found in the number of women who had not undergone screening for more than 3 years.…”
Section: To the Editormentioning
confidence: 99%